| 0.933 | 0.001 | 0.933 | Sphingosine 1-phosphate receptor agonist | | |
| 0.918 | 0 | 0.918 | Sphingosine 1-phosphate receptor 1 agonist | | |
| 0.73 | 0.001 | 0.73 | Sphingosine 1-phosphate receptor 4 agonist | | |
| 0.725 | 0.002 | 0.725 | Sphingosine 1-phosphate receptor 2 agonist | | |
| 0.457 | 0.003 | 0.457 | Sphingosine 1-phosphate receptor 5 agonist | | |
| 0.456 | 0.045 | 0.456 | Immunosuppressant | | |
| 0.431 | 0.046 | 0.431 | Vasodilator, peripheral | | |
| 0.421 | 0.038 | 0.421 | Caspase 3 stimulant | | |
| 0.437 | 0.072 | 0.437 | Cyclophilin D inhibitor | | |
| 0.274 | 0.003 | 0.274 | Sphingosine 1-phosphate receptor 1 antagonist | | |
| 0.24 | 0.004 | 0.24 | Sphingosine 1-phosphate receptor antagonist | | |
| 0.233 | 0.003 | 0.233 | Sphingosine 1-phosphate receptor 3 agonist | | |
| 0.265 | 0.042 | 0.265 | Neuropeptide Y2 antagonist | | |
| 0.262 | 0.106 | 0.262 | Immunomodulator | | |
| 0.147 | 0.004 | 0.147 | Sphingosine kinase inhibitor | | |
| 0.17 | 0.034 | 0.17 | Sphingosine 1-phosphate receptor 5 antagonist | | |
| 0.23 | 0.126 | 0.23 | Nootropic | | |
| 0.097 | 0.004 | 0.097 | Sphingosine kinase 1 inhibitor | | |
| 0.185 | 0.095 | 0.185 | Anticonvulsant | | |
| 0.301 | 0.214 | 0.301 | Antiinflammatory | | |
| 0.196 | 0.116 | 0.196 | Hypoglycemic | | |
| 0.116 | 0.04 | 0.116 | Uric acid excretion stimulant | | |
| 0.084 | 0.014 | 0.084 | Sphingosine 1-phosphate receptor 3 antagonist | | |
| 0.083 | 0.014 | 0.083 | Sphingosine kinase 2 inhibitor | | |
| 0.139 | 0.078 | 0.139 | MAP3K9 inhibitor | | |
| 0.066 | 0.011 | 0.066 | Benzodiazepine inverse agonist | | |
| 0.07 | 0.018 | 0.07 | Lysine-specific demethylase 1A inhibitor | | |
| 0.12 | 0.073 | 0.12 | Sphingosine 1-phosphate receptor 4 antagonist | | |
| 0.225 | 0.181 | 0.225 | Antiobesity | | |
| 0.075 | 0.032 | 0.075 | Beta adrenoreceptor antagonist | | |
| 0.051 | 0.01 | 0.051 | Purinergic P2X3 antagonist | | |
| 0.157 | 0.124 | 0.157 | Insulin sensitizer | | |
| 0.114 | 0.081 | 0.114 | Glutamate receptor antagonist | | |
| 0.04 | 0.009 | 0.04 | Carnitine palmitoyltransferase 1A inhibitor | | |
| 0.042 | 0.023 | 0.042 | G protein-coupled receptor agonist | | |
| 0.069 | 0.05 | 0.069 | Glutamate (mGluR group I) antagonist | | |
| 0.06 | 0.046 | 0.06 | Heme oxygenase stimulant | | |
| 0.072 | 0.059 | 0.072 | Glutamate (mGluR) antagonist | | |
| 0.072 | 0.069 | 0.072 | Adrenaline agonist | | |